REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmasi R.S. Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Full name: Farmasi R.S. Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Farmasi R.S. Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Ipoh. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on July 27, 1990. In 2022, the company reported a net sales revenue increase of 32.97%. Over the same period, its total assets decreased by 7.02%. The net profit margin of Farmasi R.S. Sdn. Bhd. decreased by 0.44% in 2022.

Headquarters
361 & 363, Jalan Silibin, Taman Saz
Ipoh; Perak; Postal Code: 30100

Contact Details: Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi R.S. Sdn. Bhd. report to view the information.
Incorporation Date:
July 27, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Biomiicron (M) Sdn. Bhd.
75%
Nattura Holdings Sdn. Bhd.
25%
Company Performance
Financial values in the chart are available after Farmasi R.S. Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
32.97%
Total operating revenue
32.97%
Operating profit (EBIT)
1637.65%
EBITDA
168.16%
Net Profit (Loss) for the Period
-468.38%
Total assets
-7.02%
Total equity
-1.66%
Operating Profit Margin (ROS)
1.57%
Net Profit Margin
-0.44%
Return on Equity (ROE)
-1.4%
Debt to Equity Ratio
-30.54%
Quick Ratio
0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?